4 Recruiting Acute Biphenotypic Leukemia Phase 2 Clinical Trials
Active phase 2 studies for acute biphenotypic leukemia enrolling across the USA. Verify eligibility and contact site coordinators.
All Acute Biphenotypic Leukemia studiesPhase 2 Studies for Acute Biphenotypic Leukemia
🔵 Active, Not Recruiting Phase2
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔ 🟢 Recruiting Phase2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
📍 Children's Hospital of Los Angeles — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔